Main Menu

A Blood Test to Screen For Colorectal Cancer? Epigenomics Has It

The Colon Cancer Podcast – Epigenomics

Noel Doheny, CEO of Epigenomics, spoke with me during Tomorrow Can’t Wait, the 2017 Colorectal Cancer Alliance conference. Epigenomics has developed the first FDA  and PMA approved liquid biopsy test to screen for colorectal cancer.

Please like & share:

, , ,

%d bloggers like this: